THYSSENKRUPP AG (TKA.DE)

DE0007500001 - Common Stock

2.889  -0.09 (-2.92%)

Fundamental Rating

3

TKA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 40 industry peers in the Metals & Mining industry. The financial health of TKA is average, but there are quite some concerns on its profitability. TKA has a valuation in line with the averages, but on the other hand it scores bad on growth.



1

1. Profitability

1.1 Basic Checks

TKA had negative earnings in the past year.
TKA had a positive operating cash flow in the past year.
In multiple years TKA reported negative net income over the last 5 years.
Of the past 5 years TKA 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of TKA (-8.14%) is worse than 94.74% of its industry peers.
TKA has a worse Return On Equity (-22.50%) than 94.74% of its industry peers.
Industry RankSector Rank
ROA -8.14%
ROE -22.5%
ROIC N/A
ROA(3y)-1.17%
ROA(5y)4.39%
ROE(3y)-3.54%
ROE(5y)13.95%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of TKA (7.03%) is worse than 81.58% of its industry peers.
TKA's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for TKA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-14.9%

4

2. Health

2.1 Basic Checks

TKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
TKA has about the same amout of shares outstanding than it did 1 year ago.
TKA has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, TKA has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.50, we must say that TKA is in the distress zone and has some risk of bankruptcy.
TKA has a Altman-Z score of 1.50. This is comparable to the rest of the industry: TKA outperforms 42.11% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that TKA is not too dependend on debt financing.
TKA has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. TKA outperforms 86.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 1.5
ROIC/WACCN/A
WACC6.76%

2.3 Liquidity

TKA has a Current Ratio of 1.85. This is a normal value and indicates that TKA is financially healthy and should not expect problems in meeting its short term obligations.
TKA has a Current ratio of 1.85. This is in the better half of the industry: TKA outperforms 65.79% of its industry peers.
TKA has a Quick Ratio of 1.16. This is a normal value and indicates that TKA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of TKA (1.16) is better than 63.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.16

3

3. Growth

3.1 Past

The earnings per share for TKA have decreased strongly by -141.66% in the last year.
TKA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.76% yearly.
The Revenue for TKA has decreased by -10.81% in the past year. This is quite bad
TKA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.00% yearly.
EPS 1Y (TTM)-141.66%
EPS 3YN/A
EPS 5Y-18.76%
EPS Q2Q%-150.44%
Revenue 1Y (TTM)-10.81%
Revenue growth 3Y9.11%
Revenue growth 5Y-2%
Sales Q2Q%-8.49%

3.2 Future

TKA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 61.24% yearly.
Based on estimates for the next years, TKA will show a decrease in Revenue. The Revenue will decrease by -1.02% on average per year.
EPS Next Y32.84%
EPS Next 2Y85.03%
EPS Next 3Y61.24%
EPS Next 5YN/A
Revenue Next Year-5.69%
Revenue Next 2Y-2.26%
Revenue Next 3Y-1.02%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

TKA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
TKA is valuated cheaply with a Price/Forward Earnings ratio of 3.67.
Based on the Price/Forward Earnings ratio, TKA is valued cheaper than 94.74% of the companies in the same industry.
TKA is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 3.67

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.17

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TKA's earnings are expected to grow with 61.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.03%
EPS Next 3Y61.24%

0

5. Dividend

5.1 Amount

No dividends for TKA!.
Industry RankSector Rank
Dividend Yield N/A

THYSSENKRUPP AG

FRA:TKA (9/16/2024, 5:29:55 PM)

2.889

-0.09 (-2.92%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.80B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.67
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.14%
ROE -22.5%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 7.03%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.16
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.85
Quick Ratio 1.16
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-141.66%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y32.84%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-10.81%
Revenue growth 3Y9.11%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y